UK | pharmaphorum

UK

News

MHRA clears Moderna COVID vaccine for 12 to 17 year olds

The Moderna COVID-19 vaccine has become the second jab to be authorised for use in England, Scotland and Wales in children aged 12 to 17 after getting the nod from the Medicines and healthc

News

UK adults asked to record coughs to improve COVID detection

Researchers in the UK are asking adults who have taken a COVID-19 test in the last 72 hours to record themselves coughing, breathing and speaking to help develop new ways to detect infectio

News

London, January 26, 2020. People wearing a face masks to protecting themself because of epidemic in China. Selective Focus. Concept of coronavirus quarantine. MERS-Cov, middle East respiratory syndrome coronavirus, Novel coronavirus 2019-nCoV.

UK cues up more Pfizer/BioNTech vaccines as price row looms

The UK government has started ordering COVID-19 vaccines for a 2022 booster campaign, including a 32 million-dose order for the Pfizer/BioNTech shot, even before third doses for 2021 have b

News

Ardelyx’s-ambition-to-revolutionise-kidney-treatment

AZ gets European approvals for Forxiga in chronic kidney dis...

AstraZeneca's Forxiga has become the first SGLT2 inhibitor to be approved in Europe for use in people with chronic kidney disease, extending its lead over rival drugs in the class.

News

Pfizer and Flynn in the firing line again over UK epilepsy d...

The UK's Competition and Markets Authority (CMA) has resurrected a complaint against Pfizer and Flynn Pharma, claiming the two companies charged the NHS excessive prices for a widely-used e

News

UK extends COVID vaccination to 16 and 17-year-olds

The UK government has confirmed that the national COVID-19 vaccination campaign will be extended to include 16 and 17-year-old children, to tackle an increase in spread of the virus in youn

MHRA clears Moderna COVID vaccine for 12 to 17 year olds

UK adults asked to record coughs to improve COVID detection

UK cues up more Pfizer/BioNTech vaccines as price row looms

AZ gets European approvals for Forxiga in chronic kidney dis...

Pfizer and Flynn in the firing line again over UK epilepsy d...

UK extends COVID vaccination to 16 and 17-year-olds

Ambrosia's sweet $100m round, and other biofinancings

Using AI-driven synthetic personas to take your insights fur...

UK

Editor's Picks